Application of the Gross Motor Function Measure in children with conditions other than cerebral palsy: A systematic

Hirokazu Abe1, Shuhei Higashi2, Nobuaki Himuro3

  • 1Department of Health Care and Child Development, Saitama Children's Medical Center, Saitama, Japan.

Insights

The Gross Motor Function Measure (GMFM) is widely used in pediatric conditions beyond cerebral palsy (CP), but its validation is insufficient. More rigorous studies are needed to ensure accurate measurement of gross motor function in diverse pediatric populations.

Area of Science:

  • Pediatric Rehabilitation
  • Movement Science
  • Clinical Measurement

Background:

  • The Gross Motor Function Measure (GMFM) is a standard tool for assessing motor function in children.
  • Its application has extended beyond cerebral palsy (CP) to various other pediatric conditions.
  • However, the psychometric properties and clinical utility of the GMFM in these diverse populations require thorough investigation.

Purpose of the Study:

  • To systematically review and evaluate the application and measurement properties of the GMFM in children with conditions other than CP.
  • To assess the quality of evidence supporting GMFM use in non-CP pediatric populations.

Main Methods:

  • A comprehensive systematic review of five electronic databases was performed.
  • Studies utilizing the GMFM in pediatric populations with conditions other than CP were identified.
  • Methodological quality and measurement properties (reliability, validity, responsiveness) were assessed using established criteria.

Main Results:

  • 210 studies were included, examining eight conditions including acquired brain injury, spinal muscular atrophy, and Down syndrome.
  • Evidence quality was generally low to very low due to small sample sizes and methodological limitations.
  • Reliability was generally sufficient, but content validity, construct validity, and responsiveness showed variable or insufficient evidence across conditions, with inadequate reporting and validation in clinical application.

Conclusions:

  • The GMFM's validation for pediatric conditions beyond CP is currently insufficient, despite its widespread clinical use.
  • There is a critical need for enhanced methodological rigor and content validity verification.
  • Clinicians must exercise caution when interpreting GMFM results in non-CP populations until robust validation is established.
Abstract

Related Concept Videos